Welcome to our dedicated page for Arkema news (Ticker: ARKAY), a resource for investors and traders seeking the latest updates and insights on Arkema stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Arkema's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Arkema's position in the market.
Arkema plans to double its UV curable resins production capacity at its Nansha plant in location value="LC/cn"China to meet rising demand in location value="LR/asp"Asia. This expansion aligns with the company's strategy to boost its Coating Solutions segment. The plant will also focus on carbon-neutral growth through energy efficiency and renewable energy sources. Set to commence in H2 2023, this investment supports Arkema's ambition to enhance its innovative materials portfolio, catering to sectors driven by 5G technology and sustainable practices.
On November 30, 2021, Arkema reported a total of 76,736,476 shares outstanding. The total number of voting rights, including shares held by the company, is 87,661,718, while the number excluding these shares stands at 84,882,120. This disclosure highlights the company’s voting structure, which is significant for shareholders and potential investors monitoring corporate governance aspects.
Arkema announces the appointment of Armand Ajdari as its new Chief Technology Officer, effective January 1, 2022. Reporting to Chairman and CEO Thierry Le Hénaff, Ajdari will be integral to the company's focus on innovation and sustainable solutions. He brings over 30 years of R&D experience from Saint-Gobain, enhancing Arkema's ambition to become a leader in Specialty Materials by 2024. The company reported sales of approximately €8 billion in 2020 and aims to strengthen its position in the materials market.
Arkema has executed a share buyback program, repurchasing 2,726,829 shares for €300 million between May 21, 2021 and November 24, 2021. Of these, 276,394 shares totaling €30 million are designated for employee share plans, while 2,450,435 shares will be cancelled in Q1 2022. This strategic move is part of Arkema's commitment to enhancing shareholder value as it transitions to a focus on Specialty Materials, which accounted for 82% of sales in 2020.
Arkema has announced its share buyback transactions from November 22 to 26, 2021, in accordance with EU regulations. A total of 93,254 shares were repurchased at a weighted average price of €124.1473 per share. The transactions reflect Arkema's commitment to shareholder value and efficient capital management. Detailed transaction data, including individual buyback amounts and prices, is publicly available on the Group's website.
Arkema announced the execution of share buyback transactions from November 15 to November 19, 2021, as part of its market strategy. A total of 95,000 shares were repurchased at a weighted average price of 122.7829 EUR. These transactions are in compliance with Article 5 §2 of Regulation (EU) No 596/2014, demonstrating Arkema's commitment to shareholder value. The transactions took place across multiple trading days and markets, highlighting a structured approach towards share repurchase activities.
Arkema inaugurates the Christian Collette Center of Excellence for batteries at its Pierre-Bénite Research Center, increasing Kynar® PVDF fluoropolymer production capacity by 50% to meet rising demand for lithium-ion battery materials. The Group targets €1 billion in battery sales by 2030. This investment aligns with its strategy to leverage opportunities in clean mobility and battery technologies, supported by State funding under the France Relance plan. The center aims to accelerate the development of advanced battery materials.
Summary not available.
Arkema has conducted share buyback transactions from November 8 to November 12, 2021, in compliance with EU regulations. A total of 46,278 shares were repurchased at a weighted average price of €119.1751. Specific transactions included 4,717 shares at €116.9599 on November 8, and 23,000 shares at €118.1961 on November 9. This buyback initiative could impact the share price and improve shareholder value by reducing the number of outstanding shares.
Arkema announced its share capital and voting rights details as of October 31, 2021. The company currently has a total of 76,736,476 shares outstanding, with 87,310,191 voting rights (including shares held by the company) and 84,648,406 voting rights (excluding shares held by the company). This data indicates the company's governance structure and shareholder engagement metrics, providing valuable insights for investors looking at its stock performance.